Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Loss and Comprehensive Loss (Unaudited)

v3.22.1
Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
EXPENSES    
Research and development $ 4,388 $ 5,642
General and administrative 2,838 2,342
Total operating expenses 7,226 7,984
OTHER INCOME (EXPENSE)    
Interest income 4 8
Interest expense [note 6] (357)  
Other income (expense) 6 (23)
Total other (expense) (347) (15)
Net loss and comprehensive loss $ (7,573) $ (7,999)
Basic and diluted net loss per common share [note 7[d]] $ (0.80) $ (1.30)
Weighted average shares used in computation of basic and diluted net loss per common share [note 7[d]] 9,458,745 6,131,821